Category: Labor
Poster Session I
The trial enrolled 417 subjects. In the ITT analysis, the probability that the risk difference would be less than 10, 5, and 0 percentage points were 0.99, 0.99, and 0.89, respectively. The Bayesian mean risk difference estimate was -5.0 (95% credible interval −12.8 to 2.7, Table). Similar results were noted when performing the analysis on the PP population (Table). The probability that the risk difference would be less than 0 percentage points was 0.92, and the Bayesian mean estimate of the risk difference was -5.8 (95% credible interval −13.7 to 2.1, Table).
Conclusion: Dilapan-S has a high probability of decreasing cesarean rates in patients undergoing pre-induction cervical ripening compared with Foley balloon. Depending on price differences, the savings from lower cesarean and improved patient satisfaction may make Dilapan-S a suitable alternative to Foley.
Antonio F. Saad, MD
Associate Professor in Maternal Fetal Medicine and Critical Care
University of Texas Medical Branch
Galveston, Texas, United States
Claudia Pedroza, PhD
McGovern Medical School, University of Texas Health Science Center at Houston
Houston, Texas, United States
George R. Saade, MD
Professor & Chief of Obstetrics & Maternal-Fetal Medicine
University of Texas Medical Branch
Galveston, Texas, United States